Wei Yong Shen (申维勇), MD, PhD
Wei Yong Shen serves as Vice President of Preclinical Development. He has more than 25 years of experience in basic and translational research in retinal diseases. Dr. Shen is a fully trained ophthalmologist and has developed numerous animal models using various species of animals including novel transgenic mice to study anti-VEGF agents and gene therapy for wet and dry forms of age-related macular degeneration, diabetic retinopathy and retinal degenerations. His body of work has led to over 90 publications in the fields of Ophthalmology and Neuroscience. His past positions include Senior Research Fellow and Laboratory Head at the University of Sydney, Senior Scientist and In Vivo Team Leader at Bausch & Lomb, Peter Doherty Fellow at the University of Melbourne, and Research Officer at the University of Western Australia. Dr. Shen received his medical training in ophthalmology at the PLA General Hospital and China/Japan Friendship Hospital. He earned his PhD in Ophthalmology and Visual Sciences (with distinction) at the University of Western Australia, Master’s degree in Medicine (Ophthalmology) at PLA General Hospital, and medical degree at Shandong University.